IP Library Granted Patent US 11,345,903
Granted Patent B2
US 11,345,903 · App. 16/953,253 · Granted May 31, 2022

Engineered enzymes

Inventors: Benjamin Mijts (Boulder, CO); Juhan Kim (Boulder, CO); Aamir Mir (Boulder, CO); Kyle Seamon (Boulder, CO); Andrew Garst (Boulder, CO)
Assignee: Inscripta, Inc.
C12N9/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,345,903
App. No.
16/953,253
Granted
May 31, 2022
Kind
B2
Abstract

The present disclosure provides engineered RNA-guided enzymes for editing live cells.

Claims (17)

1. An engineered nucleic acid-guided nuclease with a lowered cutting activity relative to the nucleic acid-guided nuclease having the sequence of SEQ ID No. 1, wherein the engineered nucleic acid-guided nuclease has a sequence comprising any of SEQ ID Nos. 8, 9, 10 or 15.

2. The engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 8.

3. The engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 9.

4. The engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 10.

5. The engineered nucleic acid-guided nuclease of claim 1 comprising SEQ ID No. 15.

6. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 .

7. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 2.

8. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 3.

9. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 11.

10. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 12.

11. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 13.

12. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 14.

13. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 67.

14. An enzyme cocktail comprising an engineered nucleic acid-guided nuclease of claim 1 and SEQ ID No. 68.

15. An enzyme cocktail comprising at least two of the engineered nucleic acid-guided nucleases of claim 1 .

16. An enzyme cocktail comprising at least three of the engineered nucleic acid-guided nucleases of claim 1 .

17. An enzyme cocktail comprising all of the engineered nucleic acid-guided nucleases of claim 1 .

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Sep 15, 2025
From: INSCRIPTA, INC.,; MANUS INSCRIPTA, INC.
To: MANUS INSCRIPTA, INC.
Reel/Frame 072252/0203 →
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2020
From: MIJTS, BENJAMIN; KIM, JUHAN; MIR, AAMIR; SEAMON, KYLE; GARST, ANDREW
To: INSCRIPTA, INC.
Reel/Frame 054424/0841 →
Continuity (5)
Continuation 16844079 · Apr 9, 2020
Continuation 16798315 · Feb 22, 2020
Continuation 16658948 · Oct 21, 2019
Provisional Application 62748668 · Oct 22, 2018
Related Publication 20210155912A1 · May 27, 2021